Lpl Financial LLC Innate Pharma Sa Transaction History

Lpl Financial LLC

  • $183 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$4.34 - $6.06 $79,856 - $111,504
-18,400 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$3.04 - $8.1 $55,936 - $149,040
18,400 New
18,400 $114,000
Q2 2021

Aug 13, 2021
SELL
$3.29 - $4.61 $39,480 - $55,320
-12,000 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$4.09 - $4.83 $49,080 - $57,960
12,000 New
12,000 $52,000

Others Institutions Holding IPHA

# of Institutions
10
Shares Held
254K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $155M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email